Cardiovascular Medicine

Cardiovascular Medicine Faculty

Jamie Beth Conti, M.D., F.A.C.C Jamie Beth Conti, M.D., F.A.C.C
Division of Cardiovascular Medicine
Professor of Medicine, Interim Chief
Director, Clinical Cardiac Electrophysiology
Program Director, Clinical Cardiac Electrophysiology and General Cardiovascular Diseases

e-mail: contijb@medicine.ufl.edu
352-392-2469

Training:

Degree
Program
Institution Field/Specialty
AB Harvard University Biology
MD University of Florida School of Medicine  
Residency Emory University Internal Medicine
Fellowship University of Florida Cardiovascular Medicine

Academic Interests:

Dr. Conti is primarily involved in intracardiac device trials. She directs both the clinical cardiac electrophysiology fellowship as well as the general cardiovascular diseases fellowship.

Clinical Interests:

Arrythmia management, implantable devices, pregnancy and arrhythmias

Representative Publications:

  • Sears, S.F., Vazquez Sowell, L., Kuhl, E.A., Handberg, E., Kron, J., Aranda, J.A.,& Conti, J.B. (2006). Quality of death: Implantable cardioverter defibrillators and proactive care. Pacing and Clinical Electrophysiology, 6, 637-642.
  • Naccarelli G, Conti JB, DiMarco JP, Tracy CM. Task Force 6: Training in Specialized Electrophysiology, Cardiac Pacing, and Arrhythmia Management. J Am Coll Cardiol 2006:904-910.
  • 3. Sears, S.F., Shea, J.B., & Conti, J.B. (2005). The cardiology patient page: How to respond to an ICD shock. Circulation, e380-e383.
  • Whang, W., Albert, C.M., Sears, S.F., Lampert, R., Conti, J.B., Wang, P.J., Singh, J.P., Ruskin, J.M., Muller, J.E., Mittleman, M.A. for the TOVA investigators. (2005). Depression as a predictor for appropriate shocks among patients with implantable cardioverter-defibrillators: Results from the Triggers of Ventricular Arrhythmias (TOVA) Study. Journal of the American College of Cardiology, 45, 1090-1095.
  • Aranda, J., Woo, G.W., Schofield, R., Handberg, E., Hill, J., Curtis, A.B., Sears, S.F., Goff, S.J., Pauly, D., & Conti, J.B. (2005). Management of heart failure after cardiac resynchronization therapy: Integrating advanced heart failure treatment with optimal device function. Journal of the American College of Cardiology, 46, 2193-2198.

Visit Pubmed for full list of publications

Primary Navigation